Advancing the global cannabis industry
The foremost source of independent data, intelligence and strategy for the cannabis industry.
Issue 121 of the International Cannabis Weekly out now
The Global Cannabis Report available for download now
Issue 120 of the International Cannabis Weekly out now
The Cannabis World Map
Click each continent to view key statistics on healthcare, market size and more
Europe
Latin America
North America
Oceania
Africa
Asia
About Us
Learn MoreProhibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence.
Within two years, we have become the world’s leading provider of market insights and strategic consultancy for this emerging frontier. We firmly believe that data, insights and education will unlock the societal and commercial potential of cannabis.
Our research and content teams routinely share the latest legislative developments and key trends in the industry - information that is regularly cited by political leaders, investment banks and Fortune 500 companies.
Our consultancy team works with investors, operators and regulators to identify and execute opportunities across multiple jurisdictions. We advise our private clients on licensing, regulatory and business opportunities.
Our Services
Find out moreData /
Bespoke Research, Polling, Consumer Insight, Pricing, Market Forecasting.
Intelligence /
Policy & Compliance, Regulatory Guidance, Supply / Demand.
Strategy /
Market Analysis / Entry, Business Development, Licensing, Partnerships.
ARE YOU READY TO EXPLORE OPPORTUNITY IN THE CANNABIS INDUSTRY?
News + Insights
View All07.11.2019
The global legal cannabis market is forecast to be worth up to US$103.9 billion by the year 2024, driven, in the most part, by the burgeoning international medicinal cannabis market,...
Key Insights from The Global Cannabis Report
28.10.2019
Since legalising medical cannabis in 2017, Germany has become a leading power in the European cannabis industry and is set to become a behemoth in the global market in the...
The Germany Cannabis Report: Key Insights
International Cannabis
Weekly
View All
08.11.2019
Issue
121
Prohibition Partners releases The Global Cannabis Report, as Sadiq Khan calls for an evidence-based approach...
01.11.2019
Issue
120
Germany’s ruling party discusses legalising adult-use cannabis, while Bernie Sanders details proposed cannabis legalisation policy....
25.10.2019
Issue
119
Gibraltar permits cannabis prescriptions for four qualifying conditions, while France authorises medical cannabis pilot programme....
18.10.2019
Issue
118
The medical cannabis sector in Germany is expected to be worth up to €7.7 billion...
Press
View PageAsia’s Medicinal Cannabis Market Could Be Worth Over $US5.8 Billion by 2024
European Cannabis Industry Offers Growth Opportunities Post-Brexit, Prohibition Partners
For press inquiries, please contact us at media@prohibitionpartners.com.
What we're saying
Two cannabis-based medicines have been approved for use by the NHS to treat epilepsy and multiple sclerosis, following the publication of new guidelines from drug advisory body NICE.
https://www.bbc.co.uk/news/health-50351868
Next week, @prohibition_p is launching a brand new report in association with @protein. To celebrate, we are hosting an exclusive event, discussing the growth of cannabis and CBD across key industries.
Register your interest: rsvp@proteinagency.com
(Name, company, title)
The European cannabis market is projected to be worth up to US$39.1 billion by 2024, with an estimated 43% of countries expected to have legalised adult-use cannabis. To learn more, download The Global Cannabis Report here: https://prohibitionpartners.com/reports/#the-global-cannabis-report